Alison Fischer, MD
Dermatology · Tulsa, OKNPI 1225266307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 949 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 949 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Pfizer$1K
- Sun Pharmaceutical Industries Inc.$1K
- Lilly USA, LLC$1000
- plus $9K from 36 others
Across 238 payments — averaging $6132.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$797K
- UCB SA$362K
- Amgen$212K
- Eli Lilly$73K
- Sanofi US Services Inc.$12K
- Boehringer Ingelheim$4K
What the payments were for
- Food & beverage$17,23495%
- Education$8535%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$520
- Otezla$249
- Kerecis Omega3 SurgiClose$173
- Kerecis Omega3 GraftGuide$173
- Skyrizi$136
- EUCRISA$125
- DUOBRII$124
- VTAMA$121
- OGSIVEO$121
- Sotyktu$120
- Rinvoq$115
- ILUMYA$109
How this compares
$18,088 in reported general payments places this provider in the 90th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $177,274 |
| Dupixent PenDupilumab | 19 | $73,139 |
| Fluorouracil | 58 | $4,384 |
| Tacrolimus | 17 | $2,378 |
| Clobetasol Propionate | 37 | $2,226 |
| Ketoconazole | 72 | $1,237 |
| Doxycycline Hyclate | 59 | $942 |
| Triamcinolone Acetonide | 69 | $925 |
| Betamethasone Dipropionate | 17 | $630 |
| Mupirocin | 55 | $455 |
| Cephalexin | 45 | $401 |
| Minocycline Hcl | 22 | $396 |
| ValacyclovirValacyclovir Hcl | 12 | $209 |
| MethotrexateMethotrexate Sodium | 17 | $205 |
| Minoxidil | 16 | $196 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tulsa
- George MonksTulsa$530K
- Jeff AlexanderTulsa$41K
- Johnathan LedetTulsa$37K
- John AshleyTulsa$24K
- Mark LehmanTulsa$17K
- Kelli LovelaceTulsa$14K
- Bernard RobinowitzTulsa$14K
- Christina KendrickTulsa$13K
- Ashwini VaidyaTulsa$12K
- Lynn AndersonTulsa$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.